(VIANEWS) – The Market ended the session with ONWARD MEDICAL (ONWD.BR) rising 33.53% to €4.50 on Wednesday, after two successive sessions in a row of gains. BEL 20 fell 0.54% to €3,520.52, after four consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
ONWARD MEDICAL’s last close was €3.37, 51.79% under its 52-week high of €6.99.
About ONWARD MEDICAL
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Earnings Per Share
As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.21.
Yearly Top and Bottom Value
ONWARD MEDICAL’s stock is valued at €4.50 at 22:33 EST, way below its 52-week high of €6.99 and way above its 52-week low of €3.15.
Volume
Today’s last reported volume for ONWARD MEDICAL is 153268 which is 1999.85% above its average volume of 7299.
Volatility
ONWARD MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.38%, a negative 1.60%, and a positive 2.14%.
ONWARD MEDICAL’s highest amplitude of average volatility was 2.05% (last week), 3.24% (last month), and 2.14% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ONWARD MEDICAL’s stock is considered to be oversold (<=20).
More news about ONWARD MEDICAL (ONWD.BR).
